Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Lung Cancer - Malignant Pleural Mesothelioma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT00895648
What this trial is testing

Pemetrexed (ALIMTA) Plus Cisplatin Followed by Surgery and Radiation Therapy for Mesothelioma

Who this might be right for
MesotheliomaPleural Mesothelioma
University Health Network, Toronto 6
Not applicableStudy completedNCT06581549
What this trial is testing

Immune Microenvironment and Gene Expression Profiling in Mesothelioma

Who this might be right for
MesotheliomaMesotheliomas PleuralMesothelioma; Lung
Istituto Oncologico Veneto IRCCS 125
Not applicableNot Yet RecruitingNCT07550049
What this trial is testing

Comprehensive Oncogenomic Mapping and Exploration in Thoracic and Head & Neck Oncology

Who this might be right for
Small Cell Lung CancerHead and Neck CancerMalignant Pleural Mesothelioma
University of Kansas Medical Center 110
Not applicableLooking for participantsNCT06971848
What this trial is testing

Evaluation of Skin Tests in Biotherapy Allergies

Who this might be right for
Locally Advanced Cutaneous Squamous Cell Carcinoma of the Head and NeckMelanoma NeoplasmsSmall Cell Bronchial Carcinomas+13 more
University Hospital, Angers 70
Not applicableUnknownNCT03558932
What this trial is testing

IP3R Modulation by Cancer Genes in Mesothelioma

Who this might be right for
Malignant Mesothelioma
KU Leuven 20
Early research (Phase 1)WithdrawnNCT05375825
What this trial is testing

Phase I Evaluation of Immunotoxin LMB-100 Administered by Normothermic, Intrapleural Perfusion Following Cytoreductive Surgery in Participants With Pleural Mesotheliomas, or Pleural Effusions From Cancers Expressing Mesothelin

Who this might be right for
Malignant Pleural Mesotheliomas (Mpm)Malignant Pleural Effusions (Mpe)Epithelial Tumors, Malignant+2 more
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Study completedNCT03177668
What this trial is testing

Clinical Study of YS110 in Patients With Malignant Pleural Mesothelioma

Who this might be right for
Malignant Pleural Mesothelioma
Kissei Pharmaceutical Co., Ltd. 40
Not applicableWithdrawnNCT04214015
What this trial is testing

A Pilot Study to Explore the Role of Gut Flora in Metastatic Mesothelioma

Who this might be right for
MesotheliomaMesothelioma MalignantMesothelioma; Lung+4 more
ProgenaBiome
Not applicableWithdrawnNCT00733252
What this trial is testing

Optical Coherence Tomography of the Airway for Lung Cancer or Lung Disease

Who this might be right for
Lung CancerMalignant MesotheliomaMetastatic Cancer+2 more
Case Comprehensive Cancer Center
Early research (Phase 1)Study completedNCT02369198
What this trial is testing

MesomiR 1: A Phase I Study of TargomiRs as 2nd or 3rd Line Treatment for Patients With Recurrent MPM and NSCLC

Who this might be right for
Malignant Pleural MesotheliomaNon-Small Cell Lung Cancer
Asbestos Diseases Research Foundation 27
Testing effectiveness (Phase 2)Study completedNCT01112293
What this trial is testing

Anti-TGF Monoclonal Antibody (GC1008) in Relapsed Malignant Pleural Mesothelioma

Who this might be right for
Pleural Malignant Mesothelioma
Abramson Cancer Center at Penn Medicine 14
Testing effectiveness (Phase 2)Ended earlyNCT02357147
What this trial is testing

Study of the Safety and Efficacy of Amatuximab in Combination With Pemetrexed and Cisplatin in Subjects With Unresectable Malignant Pleural Mesothelioma (MPM)

Who this might be right for
Mesothelioma, Malignant
Morphotek 124
Testing effectiveness (Phase 2)Ended earlyNCT02004028
What this trial is testing

Window of Opportunity Study of VS-6063 (Defactinib) in Surgical Resectable Malignant Pleural Mesothelioma Participants

Who this might be right for
Malignant Pleural Mesothelioma
Verastem, Inc. 35
Large-scale testing (Phase 3)Study completedNCT03710876
What this trial is testing

Efficacy & Safety of rAd-IFN Administered With Celecoxib & Gemcitabine in Patients With Malignant Pleural Mesothelioma

Who this might be right for
Malignant Pleural Mesothelioma
Ferring Ventures Limited 53
Testing effectiveness (Phase 2)Study completedNCT00634205
What this trial is testing

Phase II Study of Valproate and Doxorubicin in Malignant Mesothelioma

Who this might be right for
Malignant Mesothelioma
European Lung Cancer Working Party 45
Testing effectiveness (Phase 2)Study completedNCT02611037
What this trial is testing

Transarterial Chemoperfusion: Cisplatin, Methotrexate, Gemcitabine for Unresectable Pleural Mesothelioma

Who this might be right for
Malignant Pleural MesotheliomaMesothelioma
H. Lee Moffitt Cancer Center and Research Institute 34
Testing effectiveness (Phase 2)UnknownNCT02497053
What this trial is testing

Four Versus Six Cycles of Pemetrexed/Platinum for MPM

Who this might be right for
Malignant Pleural Mesothelioma
Ain Shams University 70
Not applicableStudy completedNCT03412357
What this trial is testing

MesoTRAP: A Study Comparing Video-assisted Thoracoscopic Partial Pleurectomy/Decortication With Indwelling Pleural Catheter in Patients With Trapped Lung Due to Malignant Pleural Mesothelioma.

Who this might be right for
Malignant Pleural MesotheliomaTrapped Lung
Papworth Hospital NHS Foundation Trust 23
Testing effectiveness (Phase 2)Study completedNCT02649829
What this trial is testing

Autologous Dendritic Cell Vaccination in Mesothelioma

Who this might be right for
Malignant Pleural Mesothelioma
University Hospital, Antwerp 28
Not applicableNo Longer AvailableNCT03874455
What this trial is testing

Tazemetostat Expanded Access Program for Adults With Solid Tumors

Who this might be right for
Epithelioid Sarcoma (Ex-US Only)Spindle Cell SarcomaSinonasal Carcinoma+17 more
Epizyme, Inc.
Next Page